Literature DB >> 34959739

Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554.

Zachary J Tickner1, Michael Farzan1,2.   

Abstract

In the original article, Renzl, C [...].

Entities:  

Year:  2021        PMID: 34959739      PMCID: PMC8708452          DOI: 10.3390/ph14121271

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


Missing Citation

In the original article, Renzl, C.; Kakoti, A.; Mayer, G. Aptamer-Mediated Reversible Transactivation of Gene Expression by Light. Angew. Chem. Int. Ed. 2020, 59, 22414, doi:10.1002/anie.202009240 was not cited [1]. The citation has now been inserted in Section 2.8: Regulation of CRISPR-Cas Activity by Riboswitches, paragraph 2, and should read: A particularly interesting case was recently reported by Renzl et al., who incorporated aptamers to the photoreceptor PAL into gRNAs and demonstrated 546-fold regulation of mRNA levels in response to light in HeLa cells [190].
  1 in total

Review 1.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10
  1 in total
  1 in total

1.  Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach.

Authors:  Ashraf M Muhammad; Ali Zari; Nouf H Alsubhi; Maryam H Al-Zahrani; Rana Abdullah Alghamdi; Mai M Labib
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.